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A 54 year old man was referred to our hospital with gastric cancer. The patient had a history of splenectomy and a left nephrectomy as 
a result of a traffic accident 15 years earlier. The endoscopic findings were advanced gastric cancer at the lower body of the stomach. 
Abdominal ultrasonography (USG) and magnetic resonance imaging demonstrated a metastatic nodule in the S2 segment of the liver. 
Eventually, the clinical stage was determined to be cT2cN1cM1 and a radical distal gastrectomy, lateral segmentectomy of the liver 
were performed. The histopathology findings confirmed the diagnosis of intrahepatic splenosis, omental splenosis. Hepatic splenosis is 
not rare in patients with a history of splenic trauma or splenectomy. Nevertheless, this is the first report describing a patient with gastric 
cancer and intrahepatic splenosis that was misinterpreted as a liver metastatic nodule. Intra-operative USG guided fine needle aspiration 
should be considered to avoid unnecessary liver resections in patients with a suspicious hepatic metastasis.
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Introduction
Splenosis is defined as the heterotropic transplantation of splenic 
tissue onto the peritoneal and intrathoracic surfaces after splenic 
trauma or splenectomy, and this was first reported on in 1937 by 
Shaw and Shafi.(1) There is usually multiple autoimplantations of 
splenic fragments, and this can occur anyplace in the peritoneal 
cavity, but it commonly appears on the serosal surfaces of the in-
testine and mesentery, the omentum, the diaphragm and the pelvis.
(2) Most cases of splenosis are asymptomatic; however, abdominal 
symptoms such as pain, recurring Felty syndrome and intestinal 
obstruction have been reported.(2-4) Most cases have been found 
incidentally during laparotomy or autopsy, but splenosis occurs 
in up to 67% of the patients with a history of traumatic splenic 
rupture.(5) Ectopic spleen implants may be multiple,(6) but a few 
reports have demonstrated cases of an isolated hepatic location.(7,8) 
The case reports about intrahepatic splenosis are still rare, and 
it is difficult to make the differential diagnosis of hepatic spleno-
sis from hepatic adenoma, focal nodular hyperplasia, lymphoma, 
hemangioma and hepatocellualr carcinoma.(9-11) Especially, there 
has been only one report of hepatic splenosis mimicking liver me-
tastases from cancer of another organ in a patient with breast can-
cer.(12) We describe here a patient with gastric cancer and intrahe-
patic splenosis, and this was all misinterpreted to be liver metastatic 
nodules.
Case Report
A 54 old man was referred to us because gastric cancer was 
found on an annual health examination. The patient had a his-
tory of splenectomy and left nephrectomy due to a traffic accident 
15 years ago and he had no abdominal discomfort or symptoms. 
The patient has no history of hepatitis and there was no liver pa-
renchymal abnormality on the abdominal USG performed 7 years 
previously. On the physical examination, there was no remarkable 
finding except for a left paramedian incisional scar owing to the 
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previous operation. 
The serum blood count and chemistry tests were within the 
normal ranges and the patient’s serology for hepatitis B and C was 
negative. The level of carcinoembryonic antigen (CEA) and carci-
noma antigen (CA) 19-9 was 0.87 ng/ml and 34.0 U/ml, respec-
tively. 
The endoscopic findings were Borrmann type 2 advanced gas-
tric cancer at the angle of the anterior wall and it extended into the 
proper muscle layer (cT2 stage). The endocopic biopsy results con-
firmed a moderately differentiated adenocarcinoma in the stomach. 
For the staging work-up, we performed abdomen pelvic enhanced 
computed tomography (CT), USG and positron emission tomog-
raphy-computed tomography (PET-CT). The CT demonstrated 
wall thickening of the anterior wall of the antrum in the stomach, 
lymph node enlargement in the perigastric area (cN1 stage) and 
gall bladder stone. Small sized (3.5×1.5 cm) splenic tissue was seen 
on the CT scan in the left subdiaphragmatic area with no supplying 
splenic vessel (Fig. 1). 
Interestingly, a CT scan revealed no parenchymal abnormal-
ity in the liver, and a PET-CT demonstrated no focal hyper-
metabolism in the stomach and liver. However, an abdomen US 
examination revealed a 2.5×1.7 cm sized nodular heterogenous 
hypoechoic lesion with clear margins in segment II of the liver 
(Fig. 2). Superparamagnetic iron oxide (SPIO) enhanced liver MRI 
was performed in order to confirm the presence of hepatic nodule. 
Liver MRI showed a 2.0×1.5 cm sized nodule in segment two of 
the liver with slightly high signal intensity on the T2-weighted 
image and low signal intensity on the T1-weighted image. This 
nodule still showed high signal intensity on the SPIO-enhanced T2 
weighted image (Fig. 3).
We diagnosed the patient as having advanced gastric cancer 
with liver metastasis and gall bladder stone, and so we performed 
radical distal gastrectomy, including D2 lymph node dissection, 
liver lateral segmentectomy and cholecystectomy. During lapa-
rotomy, the external surface of the liver was smooth and glistening 
with one exofitic mass and during intraoperative USG, we found 
another round hypoechoic lesion in segment two of the liver pa-
renchyma. On the multiple serial sections of the liver, there were 
two encapsulated red-blue nodules, measuring 2.3×1.9 cm and 0.7
×0.6  cm, respectively, in segment II. They were located near the 
liver capsule (Fig. 4). The pathological examination of these lesions 
found a full component of red and white splenic pulp. These find-
ings along with a history of splenectomy confirmed the diagnosis 
of hepatic splenosis with no evidence of metastasis (Fig. 5). The 
histopathologic diagnosis of the radical distal gastrectomy specimen 
confirmed early gastric cancer that had invaded the submucosa, 
lymph node metastasis in 4 out of the 44 harvested regional lymph 
nodes and omental splenosis. The patient was discharged without 
complication and he did not undergo adjuvant chemotherapy. 
Fig. 1. The axial intravenous contrast 
enhanced CT scan (the portal ve-
nous phase image). (A) Note the wall 
thickening of the anterior wall of the 
antrum in the stomach and the lymph 
node enlargement in the perigastric 
area. (B) Note the 3.5×1.5 cm sized 
splenic tissue in the left subdiaphrag-
matic area with no supplying splenic 
vessel. CT = computed tomography.
Fig. 2. Ultrasound revealed a 2.5×1.7 cm sized nodular heterogenous 
hypoechoic lesion with clear margins in segment two of the liver.Kang KC, et al.
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Discussion
Gastric cancer is the most common malignancy in South Korea. 
Unlike the well-established surgical benefits for liver metastasis 
from colorectal cancer, liver resection for hepatic metastases from 
gastric cancer is not a common procedure because of the poor 
prognosis. However, the advancement of surgical techniques for 
liver resection and better perioperative management has made the 
outcome of liver resection safer. Therefore, liver resection for me-
tastasis from gastric cancer is increasingly being performed because 
complete surgical resection appears to be the only method of curing 
this disease.(13) 
The ultrasonography characteristics of hepatic splenosis is a 
hypoechoic, homogenous soft tissue mass with a thin rim of a hy-
perechoic wall, and a CT scan shows a single or multiple soft tissue 
masses with variable sizes, shapes and enhancements. Yet there is 
a possibility of not detecting liver metastasis from gastric cancer 
Fig. 3. Axial liver MRI. (A) there was a 2.0×1.5 cm sized nodule in segment two of the liver with slightly high signal intensity on the T2-weighted 
image and (B) low signal intensity on the T1-weighted image. Th   is nodule still showed high signal intensity on the superparamagnetic iron oxide 
(SPIO) enhanced T2 weighted image (C). MRI = magnetic resonance imaging.
Fig. 4. On the multiple serial sections of the liver, there were two encapsulated red-blue nodules that measured 2.3×1.9 cm (A) and 0.7×0.6 cm (B), 
respectively. Th   ey were located near the liver capsule. 
Fig. 5. Th   e pathological examination of this lesion found a full compo-
nent of red and white pulp of the spleen and this confi  rmed the diag-
nosis of splenosis, with no evidence of metastasis (H&E, ×20).Intrahepatic Splenosis in Gastric Cancer
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on a CT scan. The signal intensities and enhancement patterns of 
the splenosis on MRI appear to be identical to those of the normal 
spleen (hypointense on the T1-weighted imaging and hyperintense 
on the T2-weighted imaging).(14) So, making the differential di-
agnosis between splenosis and hepatocellular carcinoma (HCC) or 
other liver tumors by routine USG, CT and MRI is very difficult 
because splenosis has no typical radiologic findings.(10) 
On the other hand, SPIO-enhanced MRI has been reported as 
a useful diagnostic tool to differentiate hepatic splenosis from ma-
lignant hepatic tumor.(5,9) The phagocytic reticuloendothelial cells 
located in the liver and spleen show a tissue-specific distribution 
after intravenous SPIO injection and they show the loss of signal 
intensity on T2-weighted MRI. But malignant tumor shows no 
signal loss because it does not have reticuloendothelial cells. MRI 
also has the advantages over nuclear medicine techniques of higher 
spatial resolution. However, scintigraphic imaging with heat-dena-
tured technetium-99m-labeled red blood cells (RBCs) is the most 
sensitive and specific imaging modality.(15) Eventually, histologic 
examination via a localized needle biopsy or excisional biopsy dur-
ing laparotomy is the gold standard for making the diagnosis. In 
this patient, even though we did not perform a scitigraphic imaging 
technique, USG demonstrated a new intrahepatic mass, which was 
not detected five years ago, and MRI revealed high signal intensity 
on the T2-weighted image after SPIO injection. Therefore, we 
concluded the intrahepatic nodule was liver metastasis from gastric 
cancer and we performed left lateral segmentectomy of the liver.
Intra-operative US is known to be a diagnostic method that is 
more accurate for determining the number, location and circum-
ference anatomy of intra-hepatic nodules. Intra-operative US was 
performed in this case, and another intra-hepatic nodule was found 
besides the first known lesion. The other lesion was located on the 
inner side of the liver parenchyma, and this finding was suspected 
to be liver metastasis from gastric cancer. However, if we had per-
formed intra-operative US guided fine needle aspiration before liver 
resection, we could have correctly diagnosed this man’s condition 
as splenosis and there would be no need to resect the liver paren-
chyma. 
To the best of our knowledge, this is the first report to describe 
a patient with gastric cancer and intrahepatic splenosis that was 
misinterpreted as liver metastatic nodule. Hepatic splenosis is not a 
rare disease if a patient has a history of splenic injury or splenec-
tomy. SPIO enhanced MRI or scintigraphy using heat-denatured 
technetium-99m-labeled RBCs can be used to differentiate in-
trahepatic splenosis from other liver tumors. For the final analysis, 
histologic confirmation by biopsy should be performed to avoid 
unnecessary liver resection. 
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